Joint Corp JYNT.OQ JYNT.O is expected to show a fall in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Scottsdale Arizona-based company is expected to report a 56.0% decrease in revenue to $13.321 million from $30.26 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for Joint Corp is for a loss of 2 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the healthcare facilities & services peer group is also "Buy".‚Äč
Wall Street's median 12-month price target for Joint Corp is $15.50, about 27.9% above its last closing price of $11.18
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.00
0.00
-0.03
Missed
Dec. 31 2025
0.01
0.06
Beat
500
Sep. 30 2024
0.04
0.01
-0.21
Missed
-2,725‚Äč
Jun. 30 2024
-0.02
-0.02
-0.13
Missed
-630.3
‚Äč‚ÄčMar. 31 2024
0.00
-0.01
0.06
Beat
1,100
Dec. 31 2023
0.01
0.01
-0.75
Missed
-6,350‚Äč
Sep. 30 2023
0.01
0.02
-0.05
Missed
-377.8
Jun. 30 2023
0.01
-0.01
Missed
-200
This summary was machine generated August 5 at 21:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)